Literature DB >> 18026571

Neutrophils in cystic fibrosis display a distinct gene expression pattern.

Minou Adib-Conquy1, Thierry Pedron, Anne-France Petit-Bertron, Olivier Tabary, Harriet Corvol, Jacky Jacquot, Annick Clément, Jean-Marc Cavaillon.   

Abstract

We compared gene expression in blood neutrophils (polymorphonuclear leukocytes, or PMNs) collected from healthy subjects with those of cystic fibrosis (CF) patients devoid of bacterial colonization. Macroarray analysis of 1050 genes revealed upregulation of 62 genes and downregulation expression of 27 genes in CF blood PMNs. Among upregulated genes were those coding for vitronectin, some chemokines (particularly CCL17 and CCL18), some interleukin (IL) receptors (IL-3, IL-8, IL-10, IL-12), all three colony-stimulating factors (G-, M-, GM-CSF), numerous genes coding for molecules involved in signal transduction, and a few genes under the control of gamma-interferon. In contrast, none of the genes coding for adhesion molecules were modulated. The upregulation of six genes in CF PMNs (coding for thrombospondin-1, G-CSF, CXCL10, CCL17, IKKvarepsilon, IL-10Ra) was further confirmed by qPCR. In addition, the increased presence of G-CSF, CCL17, and CXCL10 was confirmed by ELISA in supernatants of neutrophils from CF patients. When comparison was performed between blood and airway PMNs of CF patients, there was a limited difference in terms of gene expression. Only the mRNA expression of amphiregulin and tumor necrosis factor (TNF) receptor p55 were significantly higher in airway PMNs. The presence of amphiregulin was confirmed by ELISA in the sputum of CF patients, suggesting for the first time a role of amphiregulin in cystic fibrosis. Altogether, this study clearly demonstrates that blood PMNs from CF patients display a profound modification of gene expression profile associated with the disease, suggesting a state of activation of these cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18026571      PMCID: PMC2078559          DOI: 10.2119/2007-00081.Adib-Conquy

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  43 in total

Review 1.  The role of the transcription factor DP in apoptosis.

Authors:  M R Hitchens; P D Robbins
Journal:  Apoptosis       Date:  2003-10       Impact factor: 4.677

2.  Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8.

Authors:  C Taggart; R J Coakley; P Greally; G Canny; S J O'Neill; N G McElvaney
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-01       Impact factor: 5.464

3.  Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression.

Authors:  Scott D Kobayashi; Jovanka M Voyich; Cassandra L Buhl; Robert M Stahl; Frank R DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

4.  Directed neutrophil migration to IL-8 is increased in cystic fibrosis: a study of the effect of erythromycin.

Authors:  S Brennan; D Cooper; P D Sly
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

5.  Gene expression in human neutrophils during activation and priming by bacterial lipopolysaccharide.

Authors:  Yasuhiro Tsukahara; Zheng Lian; Xueqing Zhang; Constance Whitney; Yuval Kluger; David Tuck; Shigeru Yamaga; Yasuhiro Nakayama; Sherman M Weissman; Peter E Newburger
Journal:  J Cell Biochem       Date:  2003-07-01       Impact factor: 4.429

6.  Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils.

Authors:  Scott D Kobayashi; Kevin R Braughton; Adeline R Whitney; Jovanka M Voyich; Tom G Schwan; James M Musser; Frank R DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

7.  Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis.

Authors:  Harriet Corvol; Catherine Fitting; Katarina Chadelat; Jacky Jacquot; Olivier Tabary; Michele Boule; Jean-Marc Cavaillon; Annick Clement
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-01-24       Impact factor: 5.464

8.  Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways.

Authors:  Shahryar Saba; Grace Soong; Steven Greenberg; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2002-11       Impact factor: 6.914

9.  Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10.

Authors:  Anne-France Petit-Bertron; Olivier Tabary; Harriet Corvol; Jacky Jacquot; Annick Clément; Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  Cytokine       Date:  2007-12-03       Impact factor: 3.861

10.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.

Authors:  C Li; W H Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  23 in total

1.  Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa.

Authors:  Magnus Paulsson; Birendra Singh; Tamim Al-Jubair; Yu-Ching Su; Niels Høiby; Kristian Riesbeck
Journal:  J Cyst Fibros       Date:  2015-06-03       Impact factor: 5.482

2.  Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4+ regulatory T cells to impair CD8+ T-cell immunity against hepatitis B virus infection.

Authors:  Kai Dai; Ling Huang; Jing Chen; Lihua Yang; Zuojiong Gong
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

Review 3.  Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair.

Authors:  Dietmar M W Zaiss; William C Gause; Lisa C Osborne; David Artis
Journal:  Immunity       Date:  2015-02-17       Impact factor: 31.745

Review 4.  Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.

Authors:  Jason P Eiserich; Jun Yang; Brian M Morrissey; Bruce D Hammock; Carroll E Cross
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

5.  miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production.

Authors:  Sinéad Weldon; Paul McNally; Danny F McAuley; Irene K Oglesby; Christine L Wohlford-Lenane; Jennifer A Bartlett; Christopher J Scott; Noel G McElvaney; Catherine M Greene; Paul B McCray; Clifford C Taggart
Journal:  Am J Respir Crit Care Med       Date:  2014-07-15       Impact factor: 21.405

6.  RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke.

Authors:  Glen C Jickling; Bradley P Ander; Boryana Stamova; Xinhua Zhan; Dazhi Liu; Lena Rothstein; Piero Verro; Jane Khoury; Edward C Jauch; Arthur M Pancioli; Joseph P Broderick; Frank R Sharp
Journal:  Ann Neurol       Date:  2013-09-10       Impact factor: 10.422

7.  Physical Activity Regulates TNFα and IL-6 Expression to Counteract Inflammation in Cystic Fibrosis Patients.

Authors:  Ersilia Nigro; Rita Polito; Ausilia Elce; Giuseppe Signoriello; Paola Iacotucci; Vincenzo Carnovale; Monica Gelzo; Federica Zarrilli; Giuseppe Castaldo; Aurora Daniele
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

8.  Changes in transcriptome of native nasal epithelium expressing F508del-CFTR and intersecting data from comparable studies.

Authors:  Luka A Clarke; Lisete Sousa; Celeste Barreto; Margarida D Amaral
Journal:  Respir Res       Date:  2013-03-28

9.  Targeting cytosolic proliferating cell nuclear antigen in neutrophil-dominated inflammation.

Authors:  Alessia De Chiara; Magali Pederzoli-Ribeil; Pierre-Régis Burgel; Claire Danel; Véronique Witko-Sarsat
Journal:  Front Immunol       Date:  2012-10-09       Impact factor: 7.561

10.  NET balancing: a problem in inflammatory lung diseases.

Authors:  Olivia Z Cheng; Nades Palaniyar
Journal:  Front Immunol       Date:  2013-01-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.